News

FDA Clears First Blood Test to Diagnose Alzheimer’s Disease
The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...
FDA Greenlights Blood Test To Diagnose Alzheimer’s—The First Of Its Kind
The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing ...
Physician's Weekly1d
FDA Clearance of Blood Test for Alzheimer’s Inspires Cautious Optimism
Dr. Richard G. Stefanacci explains why the FDA's recent clearance of a diagnostic blood test for Alzheimer's deserves ...
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
PHILADELPHIA.Today on MSN2d
Malvern Medical Manufacturer Cleared for First-of-Its-Kind Alzheimer’s Blood Test
A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has ...
Medical Device Network on MSN11d
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
PhillyVoice9d
First-of-its-kind Alzheimer's blood test made by Malvern company gets FDA clearance
The blood test is used to detect abnormal protein deposits in the brain that are associated with Alzheimer's. The test is for ...
Monthly Prescribing Reference1y
FDA-Approved Q-Pad Test System Uses Menstrual Blood to Measure HbA1c
The Food and Drug Administration (FDA) has cleared Qvin’s Q-Pad ™ A1c Test System to measure hemoglobin ... within 5 to 10 days after shipping. The FDA clearance was based on data from a ...
Nasdaq6mon
Intelligent Bio On Track To Seek FDA Clearance For Fingerprint Drug Test
(RTTNews) - Intelligent Bio Solutions Inc. (INBS), a medical technology company, today, announced that it is on track to make an FDA 510(k) submission for its Intelligent Fingerprinting Drug ...